Shanghai Research and development of car-t cell drugs for gastric cancer and pancreatic cancer enter the US clinical trial

category:Hot
 Shanghai Research and development of car-t cell drugs for gastric cancer and pancreatic cancer enter the US clinical trial


In recent years, we have cooperated with many hospitals in China CLDN18.2CAR -The clinical study of T cells has achieved encouraging results. Li Zonghai said that this time, the FDA approved the car-t cell injection with the serial number of ct041 to enter the clinical trial, which shows the recognition of the international authorities for the original innovation and clinical research of the Chinese scientific research team. Based on the clinical research data obtained by Professor Shen Lins team of Peking University Cancer Hospital, FDA approved the clinical trial to enter phase IB directly, to carry out the safety research of candidate drugs, and to observe the effectiveness at the same time.

(function(){(window.slotbydup=window.slotbydup||[]).push({id:u5811557,container:ssp_5811557,async:true});})(); The relevant recommendation media revealed that the US biological research base has repeatedly leaked deadly virus research, saying that more than 25% of the British population may have been infected with the new crown virus, 4000 new crown papers a week, more than 23000 scientists around the world cant finish reading this article source: surging news editor: Dushu nb12556